开能健康: 关于控股股东、实际控制人及其一致行动人因可转债转股持股比例被动稀释超过1%整数倍的公告

Core Points - The company announced a rights change due to the conversion of convertible bonds, resulting in a dilution of the controlling shareholder's equity from 33.90% to 32.96% without a change in the number of shares held [1][2][3] - The company issued 2.5 million convertible bonds with a total value of 250 million yuan, approved by the China Securities Regulatory Commission, with a maturity of 6 years [1][2] - The initial conversion price of the bonds was set at 5.67 yuan per share, which has been adjusted to 5.36 yuan per share effective from May 30, 2025 [2] Rights Change Details - The total share capital of the company increased from 593,716,404 shares to 610,783,218 shares due to the conversion of bonds, resulting in a total of 17,066,814 shares being converted [2][3] - The controlling shareholder, Mr. Qu Jianguo, and his concerted actors, Mr. Qu Yaming and Ms. Wei Jia, held a total of 201,288,403 shares before the change, which remained unchanged after the conversion [2][3] - The equity dilution was a result of the bond conversion process, which does not affect the stability of the company's control or its governance structure [3][4]